Search

everythinglearnresearchcommunity

for

Search:↓

A new hair loss treatment was created using minoxidil and tretinoin in stable niosomes, which effectively released the drugs over time.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Key genes linked to hair growth and cancer were identified in hairless mice.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Washing can prevent cancer from lubricating oils, extreme body temperatures need more study, Sulfomid is not recognized, no reliable diphtheria carrier treatment except surgery, eyelid injuries should heal before repair, heterophile antibody test is specific for mononucleosis, chlorine inhalations for colds are outdated, and wheat germ is safe.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Newly made nicotinamide compounds could potentially treat cancer.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Indian Gooseberry has potential for cancer prevention and treatment and promotes hair growth.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

New compounds may help treat prostate cancer by reducing cell growth.